about
The adrenal specific toxicant mitotane directly interacts with lipid membranes and alters membrane properties depending on lipid composition.CYP2W1 is highly expressed in adrenal glands and is positively associated with the response to mitotane in adrenocortical carcinoma.Single nucleotide polymorphism array profiling of adrenocortical tumors--evidence for an adenoma carcinoma sequence?Sunitinib Inhibits Cell Proliferation and Alters Steroidogenesis by Down-Regulation of HSD3B2 in Adrenocortical Carcinoma Cells.Lack of Ubiquitin Specific Protease 8 (USP8) Mutations in Canine Corticotroph Pituitary AdenomasRole of Endocrine Gland-Derived Vascular Endothelial Growth Factor (EG-VEGF) and Its Receptors in Adrenocortical TumorsConstitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome.Low SGK1 expression in human adrenocortical tumors is associated with ACTH-independent glucocorticoid secretion and poor prognosis.Dendritic cell based immunotherapy--a promising therapeutic approach for endocrine malignancies.Livin/BIRC7 expression as malignancy marker in adrenocortical tumors.EJE prize 2014: current and evolving treatment options in adrenocortical carcinoma: where do we stand and where do we want to go?The New Molecular Landscape of Cushing's Disease.Association of mitotane with chylomicrons and serum lipoproteins: practical implications for treatment of adrenocortical carcinoma.Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer.Mitotane Inhibits Sterol-O-Acyl Transferase 1 Triggering Lipid-Mediated Endoplasmic Reticulum Stress and Apoptosis in Adrenocortical Carcinoma Cells.Survivin in adrenocortical tumors - pathophysiological implications and therapeutic potential.Ribonucleotide reductase large subunit (RRM1) gene expression may predict efficacy of adjuvant mitotane in adrenocortical cancer.Genetic Landscape of Sporadic Unilateral Adrenocortical Adenomas Without PRKACA p.Leu206Arg Mutation.Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas.DNA Methylation Is an Independent Prognostic Marker of Survival in Adrenocortical Cancer.FATE1 antagonizes calcium- and drug-induced apoptosis by uncoupling ER and mitochondria.Mutations in the deubiquitinase gene USP8 cause Cushing's disease.Differential expression of the protein kinase A subunits in normal adrenal glands and adrenocortical adenomas.Gemcitabine-Based Chemotherapy in Adrenocortical Carcinoma: A Multicenter Study of Efficacy and Predictive Factors.ERCC1 as predictive biomarker to platinum-based chemotherapy in adrenocortical carcinomas.Integrated genomic characterization of adrenocortical carcinoma.High resolution tissue mass spectrometry imaging reveals a refined functional anatomy of the human adult adrenal gland.Drug Synergism of Proteasome Inhibitors and Mitotane by Complementary Activation of ER Stress in Adrenocortical Carcinoma Cells.Expression of excision repair cross complementing group 1 and prognosis in adrenocortical carcinoma patients treated with platinum-based chemotherapy.Expression of LIN28 and its regulatory microRNAs in adult adrenocortical cancer.Epidermal growth factor receptor in adrenocortical tumors: analysis of gene sequence, protein expression and correlation with clinical outcome.High Diagnostic and Prognostic Value of Steroidogenic Factor-1 Expression in Adrenal TumorsComprehensive Pan-Genomic Characterization of Adrenocortical CarcinomaNotch1 pathway in adrenocortical carcinomas: correlations with clinical outcomeAssociation of human polyomavirus JC with peripheral blood of immunoimpaired and healthy individualsβ-catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinomaEffects of Germline CYP2W1*6 and CYP2B6*6 Single Nucleotide Polymorphisms on Mitotane Treatment in Adrenocortical Carcinoma: A Multicenter ENSAT StudyCancer-testis Antigen FATE1 Expression in Adrenocortical Tumors Is Associated with A Pervasive Autoimmune Response and Is A Marker of Malignancy in Adult, but Not Children, ACCEarly Postoperative Circulating miR-483-5p Is a Prognosis Marker for Adrenocortical CancerAlterations in Protein Kinase A Substrate Specificity as a Potential Cause of Cushing Syndrome
P50
Q31061572-2DA687C9-2BE0-4DCF-ACC0-6CFC11542F99Q34075752-C8B26487-0910-4AAA-95CE-95614B92D922Q34997163-AB76ED96-FBE6-4A34-9BC2-ED2307982173Q35972295-53B4A911-F589-414F-9955-8A921D7700B3Q36231629-137DC243-1AAE-443D-AD59-A8BCF91581D9Q36240937-D6808735-5C02-45BC-B63A-44D9F83AD87BQ36503929-EB9CFB8C-FC7E-4C67-8E7F-ABE9BB6B07DCQ36631392-C7089DA4-5786-4BB3-8B6C-18F3BD6DC959Q37088106-E031C65E-A646-4A44-B73A-FBAD0A20041CQ37705961-86240068-F050-4DCF-95DD-C455C8AC50B9Q38203130-5D99483D-0278-48B3-9DCE-5C7394CB2C79Q38594142-7EC139E8-4694-4FC2-B411-E3F61EE6C134Q38811538-5811EC22-92A9-4009-AA4A-4FAF34DF0E27Q38825846-671570AD-C415-4B70-B505-34068A52FCA0Q38840929-4F1596DE-3118-48E9-BA58-5DDDED717FADQ39246466-C551406E-3E4B-4766-B559-2168470D22C3Q39355860-00090F11-FC16-41B4-95DE-02DCEA0A0A5CQ39623012-B3527494-82F8-4344-A738-380EEAD40AAFQ40173685-4BB5E7AF-DF6B-4155-ADD7-CFC8302B8CF2Q40425821-793FF138-6345-4AE9-8989-4E1D298F1F9BQ40656348-1644C5B6-6E51-427E-BB23-BF753E423315Q41716700-BE1955BA-773D-44EA-8EA3-7DE32BA10DD5Q42053452-6FECF32A-1AD3-4FE5-A40E-98B965A39505Q47229083-3E75AF96-B53B-4B3E-85B5-6128F760F7DAQ47350252-A3C21545-3284-4166-A01B-37891F3A895CQ48315182-0A55FF9F-C62C-45C5-9212-C22C808EE23AQ49552997-2F22EFC2-1DEB-4C95-AF54-E0DD5A79DB03Q51504147-DDB8E1A5-8068-4262-A97D-DBB8E886F9BDQ51801580-5ADAB6FD-96A2-429F-81AE-0D106560340DQ54192420-D950B651-8E86-495A-B5F7-67E9053C6229Q54416267-BCAEEE05-CD84-492F-9D4A-5224507BB4E4Q56964345-F75DD5B3-1902-484E-83E4-F337A4786067Q57632333-1008E309-B08D-4B91-AF57-08494E8757B5Q61958134-33E4449D-63FD-4E72-B66C-5CEDFD34D95FQ73305677-7F8F902A-F393-434A-BAAB-EADB81646038Q82507864-FBEB790B-8CE4-4D52-8360-7BC967763FD5Q89597948-5DCB5021-168C-47A6-8C9B-D78B5812D2C5Q90399689-90246DBD-3174-4102-9446-20E7ABF90CADQ90598121-FFD54CF0-1F94-412B-ABE5-F4BDE0B7A552Q90919266-31EA7FF6-B19C-418D-B4E2-0D542592949F
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Silviu Sbiera
@ast
Silviu Sbiera
@en
Silviu Sbiera
@es
Silviu Sbiera
@nl
type
label
Silviu Sbiera
@ast
Silviu Sbiera
@en
Silviu Sbiera
@es
Silviu Sbiera
@nl
altLabel
Dr. Silviu Sbiera
@en
Sbiera S
@en
prefLabel
Silviu Sbiera
@ast
Silviu Sbiera
@en
Silviu Sbiera
@es
Silviu Sbiera
@nl
P1053
E-8128-2019
P106
P31
P496
0000-0002-6271-5533